Failed Alzheimer's trial does not kill leading theory of disease

Nature. 2016 Nov 23;540(7631):15-16. doi: 10.1038/nature.2016.21045.
No abstract available

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Alzheimer Disease / prevention & control
  • Amyloid / biosynthesis
  • Amyloid / chemistry
  • Amyloid / immunology
  • Amyloid / metabolism*
  • Antibodies, Monoclonal, Humanized / immunology
  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Clinical Trials as Topic*
  • Disease Susceptibility
  • Drug Industry / economics
  • Humans
  • Models, Biological*
  • Molecular Targeted Therapy
  • Reproducibility of Results
  • Uncertainty

Substances

  • Amyloid
  • Antibodies, Monoclonal, Humanized
  • aducanumab
  • solanezumab